BrightSpring Health Services Inc. shares plunged 13.69% in intraday trading on Friday, as investors locked in profits following a substantial pre-earnings rally, even after the company reported second-quarter results that comfortably exceeded Wall Street expectations.

The sell-off came despite BrightSpring delivering Q2 adjusted earnings per share of $0.45, surpassing the analyst consensus of $0.40, while revenue jumped 23% year-over-year to $3.87 billion, beating estimates of $3.66 billion. The company also raised its full-year revenue guidance to $15.10–$15.43 billion and lifted its adjusted EBITDA forecast. However, the stock had already surged sharply in the weeks leading up to the report, with multiple investment banks raising price targets and the shares climbing 5.07% on Thursday alone, leaving limited upside and triggering a classic “sell the news” pullback.

The sharp decline highlights how elevated market expectations and a strong run-up into earnings can outweigh even robust fundamental performance, as traders moved to capture gains following the release.